Results 121 to 130 of about 280,719 (209)

Tuft cell cysteinyl leukotrienes are necessary for rhinovirus-induced mucus metaplasia, type 2 inflammation and airway hyperresponsiveness in immature mice. [PDF]

Front Immunol
Parker DT, Bentley JK, Lei J, Domala B, Briggs HL, Singh S, Li Y, Reiner MC, Flores DA, Sliwicki AL, Flori HR, Hershenson MB.   +11 more
europepmc   +1 more source

Distinct coexisting pathologies of oral malignant peripheral nerve sheath tumor with melanin pigmentation and indolent small lymphocytic lymphoma. [PDF]

Discov Oncol
Jakka S, Narayan R, Prasad A.
europepmc   +1 more source

Corrigendum to 'Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study' [IJID Regions, volume 17 (2025) 100786]. [PDF]

IJID Reg
Thuluva S, Paradkar V, Gunneri S, Yerroju V, Mogulla RR, Thammireddy K, Ningaiah S, Dhar C, Binayke A, Zaheer A, Awasthi A, Narang S, Reddy NC, Pandey AK, Anjaneylu CS.   +14 more
europepmc   +1 more source

Model-guided chemical environment and metabolic network design to couple pathways with cell fitness. [PDF]

Metab Eng Commun
Kakko von Koch N, Tenkanen T, Castillo S, Vidgren V, Koponen T, Krogerus K, Penttilä M, Jouhten P.   +7 more
europepmc   +1 more source

Optimized multi-epitope neoantigen human cytomegalovirus vaccine based on adenovirus vectors elicits potent antiviral immunity. [PDF]

Front Immunol
Jiang S, Zhang X, Zhao H, Liu F, Li Z, Yang X, Liu W, Lv J, Zhang Y, Zhang Y, Yu Y, Wang B, Wang Y.   +12 more
europepmc   +1 more source

De novo synthesis of plant polyketide plumbagin in yeast: a platform for sustainable production of naphthoquinones. [PDF]

Nat Prod Bioprospect
Vasav AP, Barvkar VT.
europepmc   +1 more source

Heterologous biosynthetic crosstalk with the native mansouramycin cluster in <i>Streptomyces albus</i> Del14 reveals unexpected metabolites. [PDF]

RSC Chem Biol
Stierhof M, Horbal L, Oberhäuser P, Palusczak A, Cox P, Lopatniuk M, Ruf C, Zapp J, Luzhetskyy A.   +8 more
europepmc   +1 more source

Comment on “Effectiveness of homologous or heterologous immunization regimens against SARS-CoV-2 after two doses of inactivated COVID-19 vaccine: A systematic review and meta-analysis”

Human Vaccines & Immunotherapeutics
Amin Sharifan
doaj   +1 more source

A booster dose of an inactivated SARS-CoV-2 vaccine targeting virus variants sustains protective humoral and cellular immunity. [PDF]

BMC Med
Méndez C, Rodríguez-Guilarte L, Palacios PA, Gutierrez-Vera C, Román F, Moreno-Tapia D, Ríos M, Reyes A, Cancino FA, Otero FF, Zurita C, Rivera D, Cabrera A, Duarte LF, Urzúa M, Iturriaga C, Rojas Á, Perez CM, Redlich AS, Fasce RA, Fernández J, Mora J, Ramírez E, Domínguez A, Weiskopf D, Grifoni A, Sette A, Zeng G, Meng W, Goldbatt D, Johnson M, CoronaVarCL study group, González-Aramundiz JV, Álvarez-Figueroa MJ, Abarca K, Carreño LJ, González PA, Kalergis AM, Peñaloza HF, Bueno SM.   +39 more
europepmc   +1 more source